Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization... Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. Show more
MONTREAL, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
MONTREAL, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
No dose-limiting toxicities reported in two different weekly doses in heavily pre-treated patients Preliminary evidence of dose response includes significant tumor shrinkage and one patient with...
Addition of investigational RNA-targeted medicines build upon Theratechnologies’ foundational HIV portfolio Submissions to Health Canada planned for 2025 MONTREAL, Dec. 04, 2024 (GLOBE...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.38 | 26.9503546099 | 1.41 | 1.8499 | 1.4 | 195051 | 1.67936167 | CS |
4 | 0.58 | 47.9338842975 | 1.21 | 1.8499 | 1.12 | 110988 | 1.51393374 | CS |
12 | 0.54 | 43.2 | 1.25 | 1.8499 | 1.12 | 62535 | 1.40900924 | CS |
26 | 0.44 | 32.5925925926 | 1.35 | 1.8499 | 1.12 | 50497 | 1.40557713 | CS |
52 | 0.18 | 11.1801242236 | 1.61 | 2.58 | 1.08 | 50013 | 1.52541525 | CS |
156 | -10.73 | -85.7028753994 | 12.52 | 13.04 | 0.88 | 114234 | 4.45107804 | CS |
260 | -9.33 | -83.9028776978 | 11.12 | 17.8396 | 0.88 | 152066 | 8.25108801 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales